Using β-Cell Growth Factors to Enhance Human Pancreatic Islet Transplantation*
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
This is a particularly exciting time in the field of pancreatic islet growth, development, and survival. The recent publication of a study demonstrating that human pancreatic islet transplantation is both technically and immunologically feasible has highlighted the need for large supplies of pancreatic islets or pancreatic beta cells for larger-scale islet transplantation in patients with diabetes. This, together with a rapid expansion in the past several years of the understanding of mechanisms of islet growth, development, and survival, has accelerated and invigorated efforts to therapeutically harness the cellular mechanisms responsible for pancreatic beta-cell proliferation, survival, and development and to take advantage of this new knowledge to enhance the availability, survival, and function of pancreatic beta cells in human islet transplantation for diabetes mellitus. Here, we briefly review the confluence of events that have provided optimism and energy to the islet transplant field, and we focus on peptide growth factors that eventually may be deployed in the effort to augment islet mass and function in patients with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Garcia-Ocaña, A., Takane, K. K., Syed, M. A., Philbrick, W. M., Vasavada, R. C., & Stewart, A. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1226 · Cited by 247
Self-citation
Cited by
Farilla, L., Bulotta, A., Hirshberg, B., Li Calzi, S., Khoury, N., Noushmehr, H., Bertolotto, C., Di Mario, U., Harlan, D. M., & Perfetti, R. (2003) · Endocrinology · doi:10.1210/en.2003-0323 · Cited by 664
Diabetes mellitus and genetically programmed defects in β-cell function
Bell, G. I., & Polonsky, K. S. (2001) · Nature · doi:10.1038/414788a · Cited by 475
“A number of hormones and growth factors have been shown to stimulate β-cell growth and proliferation including growth hormone, prolactin, glucagon-like peptide-1, insulin-like growth factors and parathyroid hormone-related protei”
BackgroundRegulation of pancreatic beta-cell mass
Bouwens, L., & Rooman, I. (2005) · Physiological Reviews · doi:10.1152/physrev.00025.2004 · Cited by 411
Intermediate metabolism in normal pregnancy and in gestational diabetes
Di Cianni, G., Miccoli, R., Volpe, L., Lencioni, C., & Del Prato, S. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.390 · Cited by 406
Bernal-Mizrachi, E., Wen, W., Stahlhut, S., Welling, C. M., & Permutt, M. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13785 · Cited by 382
Metadata
- Authors
- García-Ocaña, A., Vasavada, R. C., Takane, K. K., Cebrian, A., Lopez-Talavera, J. C., & Stewart, A. F.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2001-03
- Volume
- 86
- Issue
- 3
- Pages
- 984-988
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2036386129
- Cited by
- 63
- References
- 1
- FWCI
- 7.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.